Vanflyta
Vanflyta 17.7MG
What is Vanflyta?
Vanflyta is a targeted tyrosine kinase inhibitor used primarily in the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) that exhibits a specific genetic mutation, FLT3. By inhibiting FLT3 signaling, Vanflyta interferes with the proliferation of malignant cells, thereby aiming to control the progression of the disease. As with all cancer treatments, Vanflyta's usage is subject to specific medical supervision due to potential side effects and individual patient considerations.Side Effects
- Allergic reaction: Itching or hives, swelling in your face or hands, swelling or tingling in your mouth or throat, chest tightness, trouble breathing
- Dark urine or pale stools, nausea, vomiting, loss of appetite, stomach pain, yellow skin or eyes
- Dry mouth, increased thirst, muscle cramps, uneven heartbeat
Warnings
- This medicine may cause birth defects if either partner is using it during conception or pregnancy. Tell your doctor right away if you or your partner becomes pregnant. Your doctor will give you a pregnancy test within 7 days before you use this medicine to make sure you are not pregnant. Female patients should use effective birth control during treatment with this medicine and for at least 7 months after the last dose. Male patients who have female partners should use effective birth control during treatment with this medicine and for at least 4 months after the last dose.
- Do not breastfeed during treatment and for at least 1 month after the last dose.
- Tell your doctor if you have liver disease, heart disease, heart rhythm problems, or had a stem cell transplant.
- This medicine may cause heart rhythm problems (including QT prolongation, torsades de pointes).
- Oral routeMedicines used to treat cancer are very strong and can have many side effects. Before receiving this medicine, make sure you understand all the risks and benefits. It is important for you to work closely with your doctor during your treatment.
Prescription savings · · · ·
What is Vanflyta ?
Vanflyta is a targeted tyrosine kinase inhibitor used primarily in the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) that exhibits a specific genetic mutation, FLT3. By inhibiting FLT3 signaling, Vanflyta interferes with the proliferation of malignant cells, thereby aiming to control the progression of the disease. As with all cancer treatments, Vanflyta's usage is subject to specific medical supervision due to potential side effects and individual patient considerations.- Allergic reaction: Itching or hives, swelling in your face or hands, swelling or tingling in your mouth or throat, chest tightness, trouble breathing
- Dark urine or pale stools, nausea, vomiting, loss of appetite, stomach pain, yellow skin or eyes
- Dry mouth, increased thirst, muscle cramps, uneven heartbeat
- Fainting, dizziness, lightheadedness
- Fever, chills, cough, runny or stuffy nose, sore throat, body aches
- Unusual bleeding, bruising, or weakness
- This medicine may cause birth defects if either partner is using it during conception or pregnancy. Tell your doctor right away if you or your partner becomes pregnant. Your doctor will give you a pregnancy test within 7 days before you use this medicine to make sure you are not pregnant. Female patients should use effective birth control during treatment with this medicine and for at least 7 months after the last dose. Male patients who have female partners should use effective birth control during treatment with this medicine and for at least 4 months after the last dose.
- Do not breastfeed during treatment and for at least 1 month after the last dose.
- Tell your doctor if you have liver disease, heart disease, heart rhythm problems, or had a stem cell transplant.
- This medicine may cause heart rhythm problems (including QT prolongation, torsades de pointes).
- Oral routeMedicines used to treat cancer are very strong and can have many side effects. Before receiving this medicine, make sure you understand all the risks and benefits. It is important for you to work closely with your doctor during your treatment.
- Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments.
- Keep all medicine out of the reach of children. Never share your medicine with anyone.
Vanflyta Coupons & Prices
Vanflyta 17.7MG
Browse more medications: starting with V · full A-Z directory · by condition · common drugs
Medical disclaimer: This information is provided for general educational purposes only and is not medical advice. It is not a substitute for professional diagnosis or treatment. Always consult a licensed physician, pharmacist, or other qualified healthcare provider before starting, stopping, or changing any medication or treatment. Never disregard professional medical advice or delay seeking it because of something you read here. If you think you may have a medical emergency, call your doctor or 911 immediately.